Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial
Harry Bartelink(Radboud University Nijmegen), Laurence Collette(GlaxoSmithKline (Belgium)), J.J. Jager(Radboud University Nijmegen), Vincent Remouchamps(Materia Nova), Philip Poortmans(Université Paris Sciences et Lettres), Sandra Collette(University of Turin), H. Struikmans(Radboud University Nijmegen), Caroline Weltens(KU Leuven), Bing Oei(Instituut Verbeeten), Alain Fourquet(Radboud University Nijmegen), C.C. Rodenhuis(University Medical Center Utrecht), Raymond Miralbell(Hôpital Beau-Séjour), P. Maingon(Maison des Sciences sociales et des Humanités de Dijon), Paula H.M. Elkhuizen(The Netherlands Cancer Institute), Rudolf Bongartz(Centrum für Integrierte Onkologie), D.A.L. Morgan(Nottingham University Hospitals NHS Trust), Dominic A.X. Schinagl(Radboud University Nijmegen), Erik Van Limbergen, J.C. Horiot(Clinique de Genolier), René-Olivier Mirimanoff(Clinique de La Source), Jean-Bernard Dubois(Institut de Recherche en Cancérologie de Montpellier), Youlia Kirova(Institut Curie)
Cited by 679
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
|New England Journal of Medicine|2006|2.7k
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k